Mer­ck and Pfiz­er back a Michi­gan star­tup's mis­sion to ad­vance tu­mor pro­fil­ing

Dan Rhodes was lead­ing can­cer se­quenc­ing at Ther­mo Fish­er Sci­en­tif­ic when he no­ticed that, de­spite the rush of phar­ma com­pa­nies de­vel­op­ing tar­get­ed ther­a­pies, most pa­tients …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER